This federal contract award was made by the National Cancer Institute (NCI) to the University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System. The contract, valued at $247,116.20, is for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. MD Anderson will retrieve de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with proton or photon therapy at their institution. This data will be used to evaluate second cancer risks and other adverse effects associated with these radiation therapy methods. There is no set-aside designation for this contract. The research effort builds upon the US Pediatric Proton Consortium Registry, which has recruited over 3,000 pediatric proton patients since 2012. This contract represents part of NCI's efforts to address concerns about potential side effects of proton therapy and quantify the risks and benefits compared to traditional photon radiation therapy in the pediatric cancer population.
Generated 6/21/24, 9:33 AM